Atilla Soran

Prof. Atilla Soran


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2018 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
ASAtilla Soran
Atilla Soran
VOVahit Ozmen
Vahit Ozmen
SOSerdar Ozbas
Serdar Ozbas
HKHasan Karanlik
Hasan Karanlik
MMMahmut Muslumanoglu
Mahmut Muslumanoglu
RJRonald Johnson
Ronald Johnson

1 December 2021 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
ASAtilla Soran
Atilla Soran
VOVahit Ozmen
Vahit Ozmen
SOSerdar Ozbas
Serdar Ozbas
HKHasan Karanlik
Hasan Karanlik
MMMahmut Muslumanoglu
Mahmut Muslumanoglu
ESEfe Sezgin
Efe Sezgin
Background: The aim of this randomized clinical trial was to evaluate the overall survival (OS) data of patients diagnosed with de novo stage IV breast cancer (BC) who received locoregional treatment (LRT) over a 10-year follow-up. Study Design: The MF07-01 is a 1:1 multicenter, randomized clinical trial comparing the LRT with systemic therapy (ST), where ST was given to all patients either immediately after randomization or after surgical resection of the intact primary tumor. Results: A total of 278 patients were randomized and 265 patients were in the final analysis. At 10-year follow-up, survivals were 19% (95% CI 13%–28%) and 5% (95% CI 2%–12%) in the LRT group and ST group, respectively. Median survival was 46 months for the LRT group and 35 months for the ST group, and hazard of death was 29% lower in the LRT group compared with the ST group (hazard ratio [HR] 0.71; 95% CI 0.59–0.86; p = 0.0003). Conclusions: Patients with a diagnosis of de novo stage IV BC who underwent LRT followed by ST had a 14% higher chance of OS by the end of the 10-year follow-up compared with the patients who received only ST. The longer study follow-up revealed that LRT should be presented to patients when discussing treatment options. Visual

6 June 2017 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
OKOguz Kayiran
Oguz Kayiran
CCCarolyn De La Cruz
Carolyn De La Cruz
KTKaori Tane
Kaori Tane
ASAtilla Soran
Atilla Soran
Lymphedema is a chronic and progressive disorder resulting from impaired lymphatic system function. In developed countries, upper extremity lymphedema is mainly the consequence of breast cancer surgery in which axillary lymph node dissection and radiation alter upper extremity lymphatic flow. Diagnosis of lymphedema is made clinically. Nevertheless, there are numerous diagnostic tools available for disease staging. Recently, a new technology namely magnetic resonance lymphangiography has emerged in the medical field to assist in both diagnosis and management. There are non-surgical and surgical treatment options available. Non-surgical methods are always the first-line treatment; however, surgical options can be explored in appropriate patients. Recent studies focus on the prevention of lymphedema using surgical techniques utilizing axillary reverse mapping to delineate arm lymphatics from axillary lymphatics. Finding the most suitable technique for each type of lymphedema with variable stages is one of the most complicated decisions for practitioners. More studies are needed to reveal the exact biology of lymphedema to ensure complete understanding of the disease and improve outcomes.

2 February 2021 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
ASAtilla Soran
Atilla Soran
LDLutfi Dogan
Lutfi Dogan
AIArda Isik
Arda Isik
SOSerdar Ozbas
Serdar Ozbas
DTDidem Can Trabulus
Didem Can Trabulus
ESEfe Sezgin
Efe Sezgin

1 April 2015 in American Journal of Clinical Oncology
Verified
Journal Article
Closed access
ASAtilla Soran
Atilla Soran
AIAhmad Ibrahim
Ahmad Ibrahim
MKMalak Kanbour
Malak Kanbour
KMKandace McGuire
Kandace McGuire
FBFatih L. Balci
Fatih L. Balci
RJRonald Johnson
Ronald Johnson
Purpose: Studies demonstrate an increasing rate of contralateral prophylactic mastectomy (CPM). The purpose of this study is to evaluate decision making and factors influencing women’s long-term satisfaction with CPM. Descriptive analysis is used to analyze the results of our designed questionnaire approved by our Institutional Review Board. Methods: We searched our institutional cancer registry for patients diagnosed with breast cancer between 2000 and 2010. The studied time frame is of significance as this study is the first to measure response rate in questions examining patient satisfaction for >1 year after undergoing CPM. The questionnaire was mailed to all consented participants to examine factors contributing to the choice of CPM and postoperative satisfaction. Results: Of the 206 women included in the study, 147 were aged up to 50 years. Majority of women who underwent CPM in this cohort was with a bachelor’s degree or higher, married or partnered women, and women earning >$60,000/y. Almost all women were “happy with overall surgery” and would recommend CPM to other patients. Psychological factors, such as fear of recurrence, were more commonly associated with the decision for CPM in patients with invasive carcinoma. Opinions of partners, relatives, friends, and physicians further contributed to the decision to undergo surgery. The availability of reconstruction was also an influential factor in the overall decision. Conclusions: The majority of our study participants experienced long-term satisfaction with the surgical procedure of CPM. From our analysis, we can confidently say that fear of cancer recurrence and the opinions of others, among other factors, were influencing contributors toward the decision of undergoing CPM.

6 May 2010 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
ADAbuzer Dirican
Abuzer Dirican
OAOya Andacoglu
Oya Andacoglu
RJRonald Johnson
Ronald Johnson
KMKandace McGuire
Kandace McGuire
LMLisa Mager
Lisa Mager
ASAtilla Soran
Atilla Soran